 | • レポートコード：MRC2-11QY12508 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は硬化性苔癬治療のグローバル市場について調査・分析したレポートです。種類別（局所、経口、注射、その他）市場規模、用途別（病院薬局、クリニック、小売薬局、オンライン薬局、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別硬化性苔癬治療の競争状況、市場シェア ・世界の硬化性苔癬治療市場：種類別市場規模 2015年-2020年（局所、経口、注射、その他） ・世界の硬化性苔癬治療市場：種類別市場規模予測 2021年-2026年（局所、経口、注射、その他） ・世界の硬化性苔癬治療市場：用途別市場規模 2015年-2020年（病院薬局、クリニック、小売薬局、オンライン薬局、ドラッグストア） ・世界の硬化性苔癬治療市場：用途別市場規模予測 2021年-2026年（病院薬局、クリニック、小売薬局、オンライン薬局、ドラッグストア） ・北米の硬化性苔癬治療市場分析：米国、カナダ ・ヨーロッパの硬化性苔癬治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの硬化性苔癬治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の硬化性苔癬治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの硬化性苔癬治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Johnson & Johnson、Merck、Pfizer、AstraZeneca、Sandoz AG (Novartis AG)、Sanofi S.A、Bristol-Myers Squibb Company、Bausch Health、Zylera Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Lichen sclerosus is a chronic disorder of the skin, affecting the genital and anal areas. However, in some serious cases, they may appear on upper body such as arms and breast regions. According to various studies, lichen sclerosus is most common in females (after menopause), uncommon in adult males, and very rare in children. Lichen sclerosus appears by forming white spots on the affected regions, the spots may be glossy and smooth in appearance, if untreated they develop into bigger patches. In addition, lichen sclerosus may result in red or purple colored bruises, skin becomes more prone to tear, itching and bleeding. The main cause of lichen sclerosus is still unknown, it is believed to be caused by hyper-immunity reactions or by hormonal imbalance. An individual with previous skin destruction around genital or anal region, are more susceptible to develop lichen sclerosus. Corticosteroids are mainly used for the treatment and management of lichen sclerosus. Women with vulva’s lichen sclerosus are at a high risk of causing vulvar cancer.
Lichen sclerosus treatment market is expected to show healthy growth during the forecast period.
Market Analysis and Insights: Global Lichen Sclerosus Treatment Market
The global Lichen Sclerosus Treatment market size is projected to reach US$ 97.2 million by 2026, from US$ 93 million in 2020, at a CAGR of 4.4%% during 2021-2026.
Global Lichen Sclerosus Treatment Scope and Market Size
Lichen Sclerosus Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lichen Sclerosus Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GlaxoSmithKline
Johnson & Johnson
Merck
Pfizer
AstraZeneca
Sandoz AG (Novartis AG)
Sanofi S.A
Bristol-Myers Squibb Company
Bausch Health
Zylera Pharmaceuticals
Market segment by Type, the product can be split into
Topical
Oral
Injection
Other
Market segment by Application, split into
Hospital Pharmacies
Clinics
Retail Pharmacies
Online Pharmacies
Drug Stores
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lichen Sclerosus Treatment Revenue
1.4 Market by Type
1.4.1 Global Lichen Sclerosus Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Topical
1.4.3 Oral
1.4.4 Injection
1.4.5 Other
1.5 Market by Application
1.5.1 Global Lichen Sclerosus Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Clinics
1.5.4 Retail Pharmacies
1.5.5 Online Pharmacies
1.5.6 Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Lichen Sclerosus Treatment Market Perspective (2015-2026)
2.2 Global Lichen Sclerosus Treatment Growth Trends by Regions
2.2.1 Lichen Sclerosus Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lichen Sclerosus Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Lichen Sclerosus Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lichen Sclerosus Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Lichen Sclerosus Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Lichen Sclerosus Treatment Players by Market Size
3.1.1 Global Top Lichen Sclerosus Treatment Players by Revenue (2015-2020)
3.1.2 Global Lichen Sclerosus Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Lichen Sclerosus Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lichen Sclerosus Treatment Market Concentration Ratio
3.2.1 Global Lichen Sclerosus Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lichen Sclerosus Treatment Revenue in 2019
3.3 Lichen Sclerosus Treatment Key Players Head office and Area Served
3.4 Key Players Lichen Sclerosus Treatment Product Solution and Service
3.5 Date of Enter into Lichen Sclerosus Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Lichen Sclerosus Treatment Historic Market Size by Type (2015-2020)
4.2 Global Lichen Sclerosus Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Lichen Sclerosus Treatment Market Size by Application (2015-2020)
5.2 Global Lichen Sclerosus Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Lichen Sclerosus Treatment Market Size (2015-2020)
6.2 Lichen Sclerosus Treatment Key Players in North America (2019-2020)
6.3 North America Lichen Sclerosus Treatment Market Size by Type (2015-2020)
6.4 North America Lichen Sclerosus Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Lichen Sclerosus Treatment Market Size (2015-2020)
7.2 Lichen Sclerosus Treatment Key Players in Europe (2019-2020)
7.3 Europe Lichen Sclerosus Treatment Market Size by Type (2015-2020)
7.4 Europe Lichen Sclerosus Treatment Market Size by Application (2015-2020)
8 China
8.1 China Lichen Sclerosus Treatment Market Size (2015-2020)
8.2 Lichen Sclerosus Treatment Key Players in China (2019-2020)
8.3 China Lichen Sclerosus Treatment Market Size by Type (2015-2020)
8.4 China Lichen Sclerosus Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Lichen Sclerosus Treatment Market Size (2015-2020)
9.2 Lichen Sclerosus Treatment Key Players in Japan (2019-2020)
9.3 Japan Lichen Sclerosus Treatment Market Size by Type (2015-2020)
9.4 Japan Lichen Sclerosus Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Lichen Sclerosus Treatment Market Size (2015-2020)
10.2 Lichen Sclerosus Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lichen Sclerosus Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Lichen Sclerosus Treatment Market Size by Application (2015-2020)
11 India
11.1 India Lichen Sclerosus Treatment Market Size (2015-2020)
11.2 Lichen Sclerosus Treatment Key Players in India (2019-2020)
11.3 India Lichen Sclerosus Treatment Market Size by Type (2015-2020)
11.4 India Lichen Sclerosus Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Lichen Sclerosus Treatment Market Size (2015-2020)
12.2 Lichen Sclerosus Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Lichen Sclerosus Treatment Market Size by Type (2015-2020)
12.4 Central & South America Lichen Sclerosus Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Lichen Sclerosus Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Lichen Sclerosus Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Lichen Sclerosus Treatment Introduction
13.2.4 Johnson & Johnson Revenue in Lichen Sclerosus Treatment Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Lichen Sclerosus Treatment Introduction
13.3.4 Merck Revenue in Lichen Sclerosus Treatment Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Lichen Sclerosus Treatment Introduction
13.4.4 Pfizer Revenue in Lichen Sclerosus Treatment Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview
13.5.3 AstraZeneca Lichen Sclerosus Treatment Introduction
13.5.4 AstraZeneca Revenue in Lichen Sclerosus Treatment Business (2015-2020)
13.5.5 AstraZeneca Recent Development
13.6 Sandoz AG (Novartis AG)
13.6.1 Sandoz AG (Novartis AG) Company Details
13.6.2 Sandoz AG (Novartis AG) Business Overview
13.6.3 Sandoz AG (Novartis AG) Lichen Sclerosus Treatment Introduction
13.6.4 Sandoz AG (Novartis AG) Revenue in Lichen Sclerosus Treatment Business (2015-2020)
13.6.5 Sandoz AG (Novartis AG) Recent Development
13.7 Sanofi S.A
13.7.1 Sanofi S.A Company Details
13.7.2 Sanofi S.A Business Overview
13.7.3 Sanofi S.A Lichen Sclerosus Treatment Introduction
13.7.4 Sanofi S.A Revenue in Lichen Sclerosus Treatment Business (2015-2020)
13.7.5 Sanofi S.A Recent Development
13.8 Bristol-Myers Squibb Company
13.8.1 Bristol-Myers Squibb Company Company Details
13.8.2 Bristol-Myers Squibb Company Business Overview
13.8.3 Bristol-Myers Squibb Company Lichen Sclerosus Treatment Introduction
13.8.4 Bristol-Myers Squibb Company Revenue in Lichen Sclerosus Treatment Business (2015-2020)
13.8.5 Bristol-Myers Squibb Company Recent Development
13.9 Bausch Health
13.9.1 Bausch Health Company Details
13.9.2 Bausch Health Business Overview
13.9.3 Bausch Health Lichen Sclerosus Treatment Introduction
13.9.4 Bausch Health Revenue in Lichen Sclerosus Treatment Business (2015-2020)
13.9.5 Bausch Health Recent Development
13.10 Zylera Pharmaceuticals
13.10.1 Zylera Pharmaceuticals Company Details
13.10.2 Zylera Pharmaceuticals Business Overview
13.10.3 Zylera Pharmaceuticals Lichen Sclerosus Treatment Introduction
13.10.4 Zylera Pharmaceuticals Revenue in Lichen Sclerosus Treatment Business (2015-2020)
13.10.5 Zylera Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Lichen Sclerosus Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Lichen Sclerosus Treatment Revenue
Table 3. Ranking of Global Top Lichen Sclerosus Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lichen Sclerosus Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Topical
Table 6. Key Players of Oral
Table 7. Key Players of Injection
Table 8. Key Players of Other
Table 9. Global Lichen Sclerosus Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Lichen Sclerosus Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Lichen Sclerosus Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Lichen Sclerosus Treatment Market Share by Regions (2015-2020)
Table 13. Global Lichen Sclerosus Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Lichen Sclerosus Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Lichen Sclerosus Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Lichen Sclerosus Treatment Players
Table 20. Global Lichen Sclerosus Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Lichen Sclerosus Treatment Market Share by Players (2015-2020)
Table 22. Global Top Lichen Sclerosus Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lichen Sclerosus Treatment as of 2019)
Table 23. Global Lichen Sclerosus Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Lichen Sclerosus Treatment Product Solution and Service
Table 26. Date of Enter into Lichen Sclerosus Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Lichen Sclerosus Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Lichen Sclerosus Treatment Market Size Share by Type (2015-2020)
Table 30. Global Lichen Sclerosus Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Lichen Sclerosus Treatment Market Size Share by Application (2015-2020)
Table 32. Global Lichen Sclerosus Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Lichen Sclerosus Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Lichen Sclerosus Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Lichen Sclerosus Treatment Market Share (2019-2020)
Table 36. North America Lichen Sclerosus Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Lichen Sclerosus Treatment Market Share by Type (2015-2020)
Table 38. North America Lichen Sclerosus Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Lichen Sclerosus Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Lichen Sclerosus Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Lichen Sclerosus Treatment Market Share (2019-2020)
Table 42. Europe Lichen Sclerosus Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Lichen Sclerosus Treatment Market Share by Type (2015-2020)
Table 44. Europe Lichen Sclerosus Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Lichen Sclerosus Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Lichen Sclerosus Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Lichen Sclerosus Treatment Market Share (2019-2020)
Table 48. China Lichen Sclerosus Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Lichen Sclerosus Treatment Market Share by Type (2015-2020)
Table 50. China Lichen Sclerosus Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Lichen Sclerosus Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Lichen Sclerosus Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Lichen Sclerosus Treatment Market Share (2019-2020)
Table 54. Japan Lichen Sclerosus Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Lichen Sclerosus Treatment Market Share by Type (2015-2020)
Table 56. Japan Lichen Sclerosus Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Lichen Sclerosus Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Lichen Sclerosus Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Lichen Sclerosus Treatment Market Share (2019-2020)
Table 60. Southeast Asia Lichen Sclerosus Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Lichen Sclerosus Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Lichen Sclerosus Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Lichen Sclerosus Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Lichen Sclerosus Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Lichen Sclerosus Treatment Market Share (2019-2020)
Table 66. India Lichen Sclerosus Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Lichen Sclerosus Treatment Market Share by Type (2015-2020)
Table 68. India Lichen Sclerosus Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Lichen Sclerosus Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Lichen Sclerosus Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Lichen Sclerosus Treatment Market Share (2019-2020)
Table 72. Central & South America Lichen Sclerosus Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Lichen Sclerosus Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Lichen Sclerosus Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Lichen Sclerosus Treatment Market Share by Application (2015-2020)
Table 76. GlaxoSmithKline Company Details
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Product
Table 79. GlaxoSmithKline Revenue in Lichen Sclerosus Treatment Business (2015-2020) (Million US$)
Table 80. GlaxoSmithKline Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Product
Table 84. Johnson & Johnson Revenue in Lichen Sclerosus Treatment Business (2015-2020) (Million US$)
Table 85. Johnson & Johnson Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Product
Table 89. Merck Revenue in Lichen Sclerosus Treatment Business (2015-2020) (Million US$)
Table 90. Merck Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Product
Table 94. Pfizer Revenue in Lichen Sclerosus Treatment Business (2015-2020) (Million US$)
Table 95. Pfizer Recent Development
Table 96. AstraZeneca Company Details
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Product
Table 99. AstraZeneca Revenue in Lichen Sclerosus Treatment Business (2015-2020) (Million US$)
Table 100. AstraZeneca Recent Development
Table 101. Sandoz AG (Novartis AG) Company Details
Table 102. Sandoz AG (Novartis AG) Business Overview
Table 103. Sandoz AG (Novartis AG) Product
Table 104. Sandoz AG (Novartis AG) Revenue in Lichen Sclerosus Treatment Business (2015-2020) (Million US$)
Table 105. Sandoz AG (Novartis AG) Recent Development
Table 106. Sanofi S.A Company Details
Table 107. Sanofi S.A Business Overview
Table 108. Sanofi S.A Product
Table 109. Sanofi S.A Revenue in Lichen Sclerosus Treatment Business (2015-2020) (Million US$)
Table 110. Sanofi S.A Recent Development
Table 111. Bristol-Myers Squibb Company Business Overview
Table 112. Bristol-Myers Squibb Company Product
Table 113. Bristol-Myers Squibb Company Company Details
Table 114. Bristol-Myers Squibb Company Revenue in Lichen Sclerosus Treatment Business (2015-2020) (Million US$)
Table 115. Bristol-Myers Squibb Company Recent Development
Table 116. Bausch Health Company Details
Table 117. Bausch Health Business Overview
Table 118. Bausch Health Product
Table 119. Bausch Health Revenue in Lichen Sclerosus Treatment Business (2015-2020) (Million US$)
Table 120. Bausch Health Recent Development
Table 121. Zylera Pharmaceuticals Company Details
Table 122. Zylera Pharmaceuticals Business Overview
Table 123. Zylera Pharmaceuticals Product
Table 124. Zylera Pharmaceuticals Revenue in Lichen Sclerosus Treatment Business (2015-2020) (Million US$)
Table 125. Zylera Pharmaceuticals Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lichen Sclerosus Treatment Market Share by Type: 2020 VS 2026
Figure 2. Topical Features
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Other Features
Figure 6. Global Lichen Sclerosus Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Clinics Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Drug Stores Case Studies
Figure 12. Lichen Sclerosus Treatment Report Years Considered
Figure 13. Global Lichen Sclerosus Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Lichen Sclerosus Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Lichen Sclerosus Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Lichen Sclerosus Treatment Market Share by Players in 2019
Figure 18. Global Top Lichen Sclerosus Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lichen Sclerosus Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Lichen Sclerosus Treatment Revenue in 2019
Figure 20. North America Lichen Sclerosus Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Lichen Sclerosus Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Lichen Sclerosus Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Lichen Sclerosus Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Lichen Sclerosus Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Lichen Sclerosus Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Lichen Sclerosus Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
光沢苔癬治療の世界市場（～2026年） Lichen nitidus is a chronic inflammatory disease of unknown cause characterized by 1–2 mm, discrete and uniform, shiny, flat-topped, pale flesh-colored or reddish-brown papules that may appear as hypopigmented against dark skin. Occasionally, minimal scaling is present or can be induced by rubbing t…- 局所用ニキビ治療の世界市場（～2026年） Acne is the most common skin disease and topical treatment can reduce the severity and frequency of acne growth. Market Analysis and Insights: Global Topical Use Acne Treatment Market The global Topical Use Acne Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million …
- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- 脂漏性皮膚炎治療の世界市場（～2026年） Seborrhoeic dermatitis is a long-term skin disorder. Seborrhoeic dermatitis symptoms include red, scaly, greasy, itchy and inflamed skin. Market Analysis and Insights: Global Seborrheic Dermatitis Treatment Market The global Seborrheic Dermatitis Treatment market size is projected to reach US$ XX mi…
- 尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…